Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular injectables drugs.

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results ...

Novo Nordisk rebounds from 2024 lows as GLP-1 supply issues ease, partnerships expand, and valuation turns attractive. Find ...